Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level. A listing of the recalled lots is identified below.
Ranitidine Tablets, USP, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL, are being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products and vegetables.
Amneal Pharmaceuticals, LLC. has not received any reports of adverse events that have been confirmed to be directly related to this recall. Ranitidine Tablets, USP and Ranitidine Syrup (Ranitidine Oral Solution, USP), manufactured by Amneal, are prescription oral products. Ranitidine is a histamine-2 blocker, which decreases the amount of acid created by the stomach. Prescription ranitidine is approved for multiple indications, including treatment and prevention of ulcers of the stomach and intestines and treatment of gastroesophageal reflux disease.
The Ranitidine Tablets, USP and Ranitidine Syrup (Ranitidine Oral Solution, USP) subject to the recall can be identified by NDC numbers stated on the product label:
Product
Strength
Pack Size
NDC Number
Ranitidine Tablets, USP
150 mg
60 count
65162-253-06
Ranitidine Tablets, USP
150 mg
100 count
65162-253-10
Ranitidine Tablets, USP
150 mg
180 count
65162-253-18
Ranitidine Tablets, USP
150 mg
500 count
65162-253-50
Ranitidine Tablets, USP
150 mg
1000 count
65162-253-11
Ranitidine Tablets, USP
150 mg
1000 count
53746-253-10
Ranitidine Tablets, USP
300 mg
30 count
65162-254-03
Ranitidine Tablets, USP
300 mg
100 count
65162-254-10
Ranitidine Tablets, USP
300 mg
250 count
65162-254-25
Ranitidine Tablets, USP
300 mg
250 count
53746-254-02
Ranitidine Syrup (Ranitidine Oral Solution, USP)
15 mg/mL;
6 fl. oz.
473 mL
65162-664-90
The affected Ranitidine Tablets, USP and Ranitidine Syrup (Ranitidine Oral Solution, USP) were distributed directly to Wholesalers, Distributors, Retailers and Repackagers.
Amneal is notifying its direct customers via mail (UPS Standard Overnight) by mailing a recall notification letter and is arranging for return of all recalled product. Anyone with an existing inventory of the product should quarantine the recalled lots immediately.
Customers who purchased the impacted product directly from Amneal can call Stericycle at 866-918-8768, Monday – Friday, 8:00 am – 5:00 pm, EST to arrange for product return.
Consumers who have Ranitidine Tablets, USP and Ranitidine Syrup (Ranitidine Oral Solution, USP) which are being recalled should stop using the product and can call Stericycle at 866-918-8768, Monday – Friday, 8:00 am – 5:00 pm, EST for further information.
Consumers who would like to report adverse reactions or quality problems experienced with the use of this product can contact Amneal Drug Safety by phone at 1-877-835-5472, Monday thru Friday, 8:00 am – 6:00 pm, EST, or e-mail at DrugSafety@amneal.com.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to the use of this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
The following lot numbers of Ranitidine Tablets, USP, 150 mg & 300 mg and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL are included in this recall.
Ranitidine Tablets, USP, 150mg
NDC No.
Description
Lot
Expiration Date
53746-253-10
Ranitidine Tablets, USP 150mg
HB03718A
3/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HB03818A
3/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HB03918A
3/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HB04018A
3/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HC01618A
3/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HC14618A
5/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HC14718A
5/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HC14818A
5/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HC14918A
5/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HC15018A
5/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HK02318A
9/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HK02418A
9/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HK02518A
9/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HK02618A
9/2020
53746-253-10
Ranitidine Tablets, USP 150mg
HD03119A
3/2021
53746-253-10
Ranitidine Tablets, USP 150mg
HD03219A
3/2021
53746-253-10
Ranitidine Tablets, USP 150mg
HE03119A
4/2021
53746-253-10
Ranitidine Tablets, USP 150mg
HE03219A
4/2021NDC No.
Description
Lot
Expiration Date
65162-253-06
Ranitidine Tablets, USP 150mg
AR171764A
11/2019
65162-253-06
Ranitidine Tablets, USP 150mg
AR171875A
11/2019
65162-253-06
Ranitidine Tablets, USP 150mg
AR171876A
11/2019
65162-253-06
Ranitidine Tablets, USP 150mg
AR171981A
11/2019
65162-253-06
Ranitidine Tablets, USP 150mg
AR180020C
1/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180206A
1/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180207A
1/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180208A
1/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180438A
2/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180439A
2/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180481A
3/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180482A
3/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR180483A
3/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR181690A
10/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR181691A
10/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR181806A
11/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR190058A
12/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR190059A
12/2020
65162-253-06
Ranitidine Tablets, USP 150mg
AR190183A
1/2021
65162-253-06
Ranitidine Tablets, USP 150mg
AR190184A
1/2021NDC No.
Description
Lot
Expiration Date
65162-253-10
Ranitidine Tablets, USP 150mg
AR171984A
12/2019
65162-253-10
Ranitidine Tablets, USP 150mg
AR180020B
1/2020
65162-253-10
Ranitidine Tablets, USP 150mg
AR180675A
4/2020
65162-253-10
Ranitidine Tablets, USP 150mg
AR180868B
5/2020
65162-253-10
Ranitidine Tablets, USP 150mg
AR181807A
11/2020
65162-253-10
Ranitidine Tablets, USP 150mg
AR190366B
2/2021NDC No.
Description
Lot
Expiration Date
65162-253-11
Ranitidine Tablets, USP 150mg
AR171986A
12/2019
65162-253-11
Ranitidine Tablets, USP 150mg
AR171987A
12/2019
65162-253-11
Ranitidine Tablets, USP 150mg
AR180255A
1/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180441A
2/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180442A
2/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180559A
3/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180560A
3/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180594A
3/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180595A
3/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180829A
4/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180831A
5/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180832A
5/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR180868A
5/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR181807C
11/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR190085A
12/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR190086A
12/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR190087A
12/2020
65162-253-11
Ranitidine Tablets, USP 150mg
AR190124A
1/2021
65162-253-11
Ranitidine Tablets, USP 150mg
AR190542B
3/2021
65162-253-11
Ranitidine Tablets, USP 150mg
AR190609A
3/2021
65162-253-11
Ranitidine Tablets, USP 150mg
AR190610A
3/2021NDC No.
Description
Lot
Expiration Date
65162-253-18
Ranitidine Tablets, USP 150mg
AR171875B
11/2019
65162-253-18
Ranitidine Tablets, USP 150mg
AR180483B
3/2020
65162-253-18
Ranitidine Tablets, USP 150mg
AR181807B
11/2020
65162-253-18
Ranitidine Tablets, USP 150mg
AR190008B
12/2020NDC No.
Description
Lot
Expiration Date
65162-253-50
Ranitidine Tablets, USP 150mg
AR171763A
11/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171764B
11/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171874A
11/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171875C
11/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171877B
11/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171878B
11/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171982A
11/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171983A
12/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR171985A
12/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR180016A
12/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR180017A
12/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR180018A
12/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR180019A
12/2019
65162-253-50
Ranitidine Tablets, USP 150mg
AR180020A
1/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180208B
1/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180256A
1/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180291A
1/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180292A
1/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180293A
1/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180294A
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180295A
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180364A
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180365A
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180366A
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180367A
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180368A
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180440B
2/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180484A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180485A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180556A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180557A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180558A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180596A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180597A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180598A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180599A
3/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180675B
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180676A
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180677A
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180678A
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180679A
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180801A
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180802A
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180803A
4/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180869A
5/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180870A
5/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180871A
5/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180872A
5/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180994A
5/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180995A
5/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180996A
5/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180997A
6/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR180998A
6/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181158A
7/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181159A
7/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181160A
7/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181161A
7/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181692A
10/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181693A
10/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181694A
10/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181709A
10/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181710A
11/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181711A
11/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181808A
11/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR181809A
11/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190004A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190005A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190006A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190007A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190008A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190088A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190089A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190090A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190121A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190122A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190123A
12/2020
65162-253-50
Ranitidine Tablets, USP 150mg
AR190125B
1/2021
65162-253-50
Ranitidine Tablets, USP 150mg
AR190181A
1/2021
65162-253-50
Ranitidine Tablets, USP 150mg
AR190182A
1/2021
65162-253-50
Ranitidine Tablets, USP 150mg
AR190364A
2/2021
65162-253-50
Ranitidine Tablets, USP 150mg
AR190365A
2/2021
65162-253-50
Ranitidine Tablets, USP 150mg
AR190366A
2/2021
65162-253-50
Ranitidine Tablets, USP 150mg
AR190509A
3/2021
65162-253-50
Ranitidine Tablets, USP 150mg
AR190510A
3/2021Ranitidine Tablets, USP, 300mg
NDC No.
Description
Lot
Expiration Date
53746-254-02
Ranitidine Tablets, USP 300mg
HB04118A
2/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HB04218A
2/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HB04318A
2/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HB04418A
2/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HF13518A
6/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HF13618A
6/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HF13718A
6/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HF13818A
6/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HK02818A
9/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HK02918A
9/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HK03018A
9/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HK03118A
9/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HL08418A
11/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HL08518A
11/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HL08618A
11/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HL08718A
11/2020
53746-254-02
Ranitidine Tablets, USP 300mg
HB01419A
1/2021
53746-254-02
Ranitidine Tablets, USP 300mg
HB05619A
1/2021
53746-254-02
Ranitidine Tablets, USP 300mg
HB05719A
1/2021
53746-254-02
Ranitidine Tablets, USP 300mg
HB05819A
1/2021
53746-254-02
Ranitidine Tablets, USP 300mg
HB05919A
1/2021
53746-254-02
Ranitidine Tablets, USP 300mg
HB06019A
1/2021
53746-254-02
Ranitidine Tablets, USP 300mg
HB06119A
1/2021
NDC No.
Description
Lot
Expiration Date
65162-254-03
Ranitidine Tablets, USP 300mg
AR172033B
11/2019
65162-254-03
Ranitidine Tablets, USP 300mg
AR180024A
12/2019
65162-254-03
Ranitidine Tablets, USP 300mg
AR180025A
12/2019
65162-254-03
Ranitidine Tablets, USP 300mg
AR180118A
12/2019
65162-254-03
Ranitidine Tablets, USP 300mg
AR180119A
12/2019
65162-254-03
Ranitidine Tablets, USP 300mg
AR180519A
3/2020
65162-254-03
Ranitidine Tablets, USP 300mg
AR180615A
3/2020
65162-254-03
Ranitidine Tablets, USP 300mg
AR181795A
11/2020
65162-254-03
Ranitidine Tablets, USP 300mg
AR181921B
12/2020
65162-254-03
Ranitidine Tablets, USP 300mg
AR190705A
4/2021
NDC No.
Description
Lot
Expiration Date
65162-254-10
Ranitidine Tablets, USP 300mg
AR172029A
11/2019
65162-254-10
Ranitidine Tablets, USP 300mg
AR172030A
11/2019
65162-254-10
Ranitidine Tablets, USP 300mg
AR180021A
12/2019
65162-254-10
Ranitidine Tablets, USP 300mg
AR180022A
12/2019
65162-254-10
Ranitidine Tablets, USP 300mg
AR180023A
12/2019
65162-254-10
Ranitidine Tablets, USP 300mg
AR180123A
12/2019
65162-254-10
Ranitidine Tablets, USP 300mg
AR180144A
1/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180145A
1/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180146A
1/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180147A
1/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180402A
2/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180465A
2/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180466A
2/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180467A
2/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180468A
2/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR180613A
3/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR181156A
7/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR181157A
7/2020
65162-254-10
Ranitidine Tablets, USP 300mg
AR190418B
2/2021
NDC No.
Description
Lot
Expiration Date
65162-254-25
Ranitidine Tablets, USP 300mg
AR171800A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171801A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171802A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171803A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171804A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171931A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171932A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171933A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171934A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171935A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171936A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR171937A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172026A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172027A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172028A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172031A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172032A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172033A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172034A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR172035A
11/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180030A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180031A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180032A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180033A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180034A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180113A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180114A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180115A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180117A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180120A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180121A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180122A
12/2019
65162-254-25
Ranitidine Tablets, USP 300mg
AR180148A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180198A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180199A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180200A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180201A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180202A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180257A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180258A
1/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180335A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180336A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180337A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180338A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180339A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180374A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180375A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180376B
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180403A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180404A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180405A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180406A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180424A
2/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180486A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180487A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180488A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180515A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180516A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180517A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180518A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180638A
3/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180640A
4/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR180641A
4/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR181920A
12/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR181921A
12/2020
65162-254-25
Ranitidine Tablets, USP 300mg
AR190414B
2/2021
65162-254-25
Ranitidine Tablets, USP 300mg
AR190415A
2/2021
65162-254-25
Ranitidine Tablets, USP 300mg
AR190416A
2/2021
65162-254-25
Ranitidine Tablets, USP 300mg
AR190417A
2/2021
65162-254-25
Ranitidine Tablets, USP 300mg
AR190418A
2/2021
65162-254-25
Ranitidine Tablets, USP 300mg
AR190543A
3/2021
65162-254-25
Ranitidine Tablets, USP 300mg
AR190544A
3/2021
65162-254-25
Ranitidine Tablets, USP 300mg
AR190545A
3/2021
Ranitidine Syrup (Ranitidine Oral Solution, USP)
NDC No.
Description
Lot
Expiration Date
65162-664-90
Ranitidine Syrup 15mg/mL
06648001A
11/2019
65162-664-90
Ranitidine Syrup 15mg/mL
06648003A
4/2020
65162-664-90
Ranitidine Syrup 15mg/mL
06649001A
1/2021
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Safe Harbor Statement
You must be logged in to post a comment.